[Dopa metabolism in relation to the therapy of Parkinson's syndrome].
D000818:Animals; D001921:Brain / Q000378:metabolism; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D008750:Methyldopa / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D051381:Rats
D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Le métabolisme de la dopa en rapport avec la thérapeutique du syndrome de Parkinson.